Cash flow positive in the sense that finance expense relating to the Novaquest funding is not an actual cash outflow.
Expect lots of Aussies that did not get a 10% lung improvement during their 4 week trial to get back on it where they had some positive effect. The competitive advantage of bronchitol is that it only takes a few minutes and you are not tied to a nubuliser for hours per day. You can also travel with it and don't need access to a fridge which pulmozyme required to stay cold as I understand it
- Forums
- ASX - By Stock
- SNT
- share price
share price, page-7
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
-0.001(2.44%) |
Mkt cap ! $54.92M |
Open | High | Low | Value | Volume |
4.0¢ | 4.0¢ | 3.6¢ | $152.2K | 4.019M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 104121 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 99980 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 104121 | 0.039 |
2 | 218558 | 0.038 |
3 | 590243 | 0.037 |
7 | 702200 | 0.036 |
5 | 985528 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 99980 | 1 |
0.042 | 100000 | 1 |
0.043 | 200000 | 1 |
0.045 | 200000 | 1 |
0.046 | 69660 | 2 |
Last trade - 15.58pm 14/11/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |